Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (541-550 of 651) with videos related to

Pageof 66
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled AnalysisLuiz H Araujo, Philip E Lammers, Velmalia Matthews-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neckD I Rosenthal, J H Lee, R Sinard, et al.
Plos One|November 26, 2015
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing EfficiencyLuiz H Araujo, Cynthia Timmers, Konstantin Shilo, et al.
Cell Reports|July 13, 2022
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancersKezhong Chen, Airong Yang, David P Carbone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY StudyDaniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Cancer Research|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and <i>S</i>-Adenosyl-Methionine Depletion in Human Lung AdenocarcinomaMichael J Koenig, Bernice A Agana, Jacob M Kaufman, et al.
Pageof 66

Showing results (541-550 of 651) with videos related to

Sort By:
Pageof 66
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Somatic Mutation Spectrum of Non-Small-Cell Lung Cancer in African Americans: A Pooled AnalysisLuiz H Araujo, Philip E Lammers, Velmalia Matthews-Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neckD I Rosenthal, J H Lee, R Sinard, et al.
Plos One|November 26, 2015
Impact of Pre-Analytical Variables on Cancer Targeted Gene Sequencing EfficiencyLuiz H Araujo, Cynthia Timmers, Konstantin Shilo, et al.
Cell Reports|July 13, 2022
Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancersKezhong Chen, Airong Yang, David P Carbone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY StudyDaniel Morgensztern, Benjamin Besse, Laurent Greillier, et al.
Cancer Immunology, Immunotherapy : CII|July 31, 2020
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancerMingjia Li, Daniel Spakowicz, Songzhu Zhao, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
Science Advances|June 17, 2021
Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancersJiefei Han, Ruofei Yu, Jianchun Duan, et al.
The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.
Cancer Research|May 28, 2021
STK11/LKB1 Loss of Function Is Associated with Global DNA Hypomethylation and <i>S</i>-Adenosyl-Methionine Depletion in Human Lung AdenocarcinomaMichael J Koenig, Bernice A Agana, Jacob M Kaufman, et al.
Pageof 66